1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2030 2.1.2 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) 2.1.3 World Current & Future Analysis for Nucleic Acid and Oligonucleotide Therapeutics by Country/Region, 2019, 2023 & 2030 2.2 Nucleic Acid and Oligonucleotide Therapeutics Segment by Type 2.2.1 Antisense Oligonucleotides (ASO) 2.2.2 siRNA 2.2.3 mRNA 2.3 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type 2.3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) 2.4 Nucleic Acid and Oligonucleotide Therapeutics Segment by Application 2.4.1 Neuromuscular Diseases 2.4.2 hATTR 2.4.3 COVID-19 2.4.4 Other 2.5 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application 2.5.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) 3 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Player 3.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Player 3.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024) 3.1.2 Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024) 3.2 Global Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Nucleic Acid and Oligonucleotide Therapeutics by Region 4.1 Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) 4.2 Global Nucleic Acid and Oligonucleotide Therapeutics Annual Revenue by Country/Region (2019-2024) 4.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024) 4.4 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024) 4.5 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024) 4.6 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth (2019-2024) 5 Americas 5.1 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) 5.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) 5.3 Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) 6.2 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) 6.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) 7.2 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) 7.3 Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics by Region (2019-2024) 8.2 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) 8.3 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Nucleic Acid and Oligonucleotide Therapeutics Market Forecast 10.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030) 10.1.1 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030) 10.1.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.1.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.1.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.1.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.2 Americas Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030) 10.2.1 United States Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.2.2 Canada Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.2.3 Mexico Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.2.4 Brazil Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.3 APAC Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030) 10.3.1 China Nucleic Acid and Oligonucleotide Therapeutics Market Forecast 10.3.2 Japan Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.3.3 Korea Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.3.4 Southeast Asia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.3.5 India Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.3.6 Australia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.4 Europe Nucleic Acid and Oligonucleotide Therapeutics Forecast by Country (2025-2030) 10.4.1 Germany Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.4.2 France Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.4.3 UK Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.4.4 Italy Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.4.5 Russia Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.5 Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Forecast by Region (2025-2030) 10.5.1 Egypt Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.5.2 South Africa Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.5.3 Israel Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.5.4 Turkey Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 10.6 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Type (2025-2030) 10.7 Global Nucleic Acid and Oligonucleotide Therapeutics Forecast by Application (2025-2030) 10.7.1 GCC Countries Market Nucleic Acid and Oligonucleotide Therapeutics Forecast 11 Key Players Analysis 11.1 Sarepta Therapeutics 11.1.1 Sarepta Therapeutics Company Information 11.1.2 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.1.3 Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Sarepta Therapeutics Main Business Overview 11.1.5 Sarepta Therapeutics Latest Developments 11.2 Ionis Pharmaceuticals 11.2.1 Ionis Pharmaceuticals Company Information 11.2.2 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.2.3 Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Ionis Pharmaceuticals Main Business Overview 11.2.5 Ionis Pharmaceuticals Latest Developments 11.3 Alnylam 11.3.1 Alnylam Company Information 11.3.2 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.3.3 Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Alnylam Main Business Overview 11.3.5 Alnylam Latest Developments 11.4 Biogen 11.4.1 Biogen Company Information 11.4.2 Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.4.3 Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Biogen Main Business Overview 11.4.5 Biogen Latest Developments 11.5 Nippon Shinyaku 11.5.1 Nippon Shinyaku Company Information 11.5.2 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.5.3 Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Nippon Shinyaku Main Business Overview 11.5.5 Nippon Shinyaku Latest Developments 11.6 Sobi 11.6.1 Sobi Company Information 11.6.2 Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.6.3 Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Sobi Main Business Overview 11.6.5 Sobi Latest Developments 11.7 Novartis 11.7.1 Novartis Company Information 11.7.2 Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.7.3 Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Novartis Main Business Overview 11.7.5 Novartis Latest Developments 11.8 BioNTech 11.8.1 BioNTech Company Information 11.8.2 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.8.3 BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 BioNTech Main Business Overview 11.8.5 BioNTech Latest Developments 11.9 Pfizer 11.9.1 Pfizer Company Information 11.9.2 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.9.3 Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Pfizer Main Business Overview 11.9.5 Pfizer Latest Developments 11.10 Moderna Therapeutics 11.10.1 Moderna Therapeutics Company Information 11.10.2 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.10.3 Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Moderna Therapeutics Main Business Overview 11.10.5 Moderna Therapeutics Latest Developments 11.11 Jazz Pharmaceuticals 11.11.1 Jazz Pharmaceuticals Company Information 11.11.2 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.11.3 Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Jazz Pharmaceuticals Main Business Overview 11.11.5 Jazz Pharmaceuticals Latest Developments 11.12 CureVac 11.12.1 CureVac Company Information 11.12.2 CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.12.3 CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 CureVac Main Business Overview 11.12.5 CureVac Latest Developments 11.13 Regulus Therapeutics 11.13.1 Regulus Therapeutics Company Information 11.13.2 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.13.3 Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Regulus Therapeutics Main Business Overview 11.13.5 Regulus Therapeutics Latest Developments 11.14 ProQR 11.14.1 ProQR Company Information 11.14.2 ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.14.3 ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 ProQR Main Business Overview 11.14.5 ProQR Latest Developments 11.15 Secarna 11.15.1 Secarna Company Information 11.15.2 Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.15.3 Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 Secarna Main Business Overview 11.15.5 Secarna Latest Developments 11.16 MiNA Therapeutics 11.16.1 MiNA Therapeutics Company Information 11.16.2 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.16.3 MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 MiNA Therapeutics Main Business Overview 11.16.5 MiNA Therapeutics Latest Developments 11.17 Sylentis 11.17.1 Sylentis Company Information 11.17.2 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.17.3 Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Sylentis Main Business Overview 11.17.5 Sylentis Latest Developments 11.18 Arrowhead 11.18.1 Arrowhead Company Information 11.18.2 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.18.3 Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 Arrowhead Main Business Overview 11.18.5 Arrowhead Latest Developments 11.19 Silence Therapeutics 11.19.1 Silence Therapeutics Company Information 11.19.2 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.19.3 Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 Silence Therapeutics Main Business Overview 11.19.5 Silence Therapeutics Latest Developments 11.20 Dicerna 11.20.1 Dicerna Company Information 11.20.2 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered 11.20.3 Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024) 11.20.4 Dicerna Main Business Overview 11.20.5 Dicerna Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions) Table 2. Nucleic Acid and Oligonucleotide Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Antisense Oligonucleotides (ASO) Table 4. Major Players of siRNA Table 5. Major Players of mRNA Table 6. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions) Table 7. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions) Table 8. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) Table 9. Nucleic Acid and Oligonucleotide Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions) Table 10. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions) Table 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) Table 12. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Player (2019-2024) & ($ millions) Table 13. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player (2019-2024) Table 14. Nucleic Acid and Oligonucleotide Therapeutics Key Players Head office and Products Offered Table 15. Nucleic Acid and Oligonucleotide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions) Table 19. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024) Table 20. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue by Country/Region (2019-2024) & ($ millions) Table 21. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Country/Region (2019-2024) Table 22. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions) Table 23. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024) Table 24. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions) Table 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) Table 26. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions) Table 27. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) Table 28. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions) Table 29. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024) Table 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions) Table 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions) Table 32. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Country (2019-2024) & ($ millions) Table 33. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country (2019-2024) Table 34. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions) Table 35. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions) Table 36. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Region (2019-2024) & ($ millions) Table 37. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Type (2019-2024) & ($ millions) Table 38. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size by Application (2019-2024) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Nucleic Acid and Oligonucleotide Therapeutics Table 40. Key Market Challenges & Risks of Nucleic Acid and Oligonucleotide Therapeutics Table 41. Key Industry Trends of Nucleic Acid and Oligonucleotide Therapeutics Table 42. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Region (2025-2030) & ($ millions) Table 43. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Region (2025-2030) Table 44. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Type (2025-2030) & ($ millions) Table 45. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Forecast by Application (2025-2030) & ($ millions) Table 46. Sarepta Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 47. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 48. Sarepta Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 49. Sarepta Therapeutics Main Business Table 50. Sarepta Therapeutics Latest Developments Table 51. Ionis Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 52. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 53. Ionis Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Ionis Pharmaceuticals Main Business Table 55. Ionis Pharmaceuticals Latest Developments Table 56. Alnylam Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 57. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 58. Alnylam Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 59. Alnylam Main Business Table 60. Alnylam Latest Developments Table 61. Biogen Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 62. Biogen Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 63. Biogen Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 64. Biogen Main Business Table 65. Biogen Latest Developments Table 66. Nippon Shinyaku Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 67. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 68. Nippon Shinyaku Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 69. Nippon Shinyaku Main Business Table 70. Nippon Shinyaku Latest Developments Table 71. Sobi Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 72. Sobi Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 73. Sobi Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 74. Sobi Main Business Table 75. Sobi Latest Developments Table 76. Novartis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 77. Novartis Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 78. Novartis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 79. Novartis Main Business Table 80. Novartis Latest Developments Table 81. BioNTech Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 82. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 83. BioNTech Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 84. BioNTech Main Business Table 85. BioNTech Latest Developments Table 86. Pfizer Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 87. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 88. Pfizer Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 89. Pfizer Main Business Table 90. Pfizer Latest Developments Table 91. Moderna Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 92. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 93. Moderna Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 94. Moderna Therapeutics Main Business Table 95. Moderna Therapeutics Latest Developments Table 96. Jazz Pharmaceuticals Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 97. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 98. Jazz Pharmaceuticals Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 99. Jazz Pharmaceuticals Main Business Table 100. Jazz Pharmaceuticals Latest Developments Table 101. CureVac Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 102. CureVac Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 103. CureVac Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 104. CureVac Main Business Table 105. CureVac Latest Developments Table 106. Regulus Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 107. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 108. Regulus Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 109. Regulus Therapeutics Main Business Table 110. Regulus Therapeutics Latest Developments Table 111. ProQR Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 112. ProQR Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 113. ProQR Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 114. ProQR Main Business Table 115. ProQR Latest Developments Table 116. Secarna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 117. Secarna Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 118. Secarna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 119. Secarna Main Business Table 120. Secarna Latest Developments Table 121. MiNA Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 122. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 123. MiNA Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 124. MiNA Therapeutics Main Business Table 125. MiNA Therapeutics Latest Developments Table 126. Sylentis Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 127. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 128. Sylentis Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 129. Sylentis Main Business Table 130. Sylentis Latest Developments Table 131. Arrowhead Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 132. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 133. Arrowhead Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 134. Arrowhead Main Business Table 135. Arrowhead Latest Developments Table 136. Silence Therapeutics Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 137. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 138. Silence Therapeutics Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 139. Silence Therapeutics Main Business Table 140. Silence Therapeutics Latest Developments Table 141. Dicerna Details, Company Type, Nucleic Acid and Oligonucleotide Therapeutics Area Served and Its Competitors Table 142. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Product Offered Table 143. Dicerna Nucleic Acid and Oligonucleotide Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 144. Dicerna Main Business Table 145. Dicerna Latest Developments List of Figures Figure 1. Nucleic Acid and Oligonucleotide Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth Rate 2019-2030 ($ millions) Figure 6. Nucleic Acid and Oligonucleotide Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2023) Figure 8. Nucleic Acid and Oligonucleotide Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type in 2023 Figure 10. Nucleic Acid and Oligonucleotide Therapeutics in Neuromuscular Diseases Figure 11. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Neuromuscular Diseases (2019-2024) & ($ millions) Figure 12. Nucleic Acid and Oligonucleotide Therapeutics in hATTR Figure 13. Global Nucleic Acid and Oligonucleotide Therapeutics Market: hATTR (2019-2024) & ($ millions) Figure 14. Nucleic Acid and Oligonucleotide Therapeutics in COVID-19 Figure 15. Global Nucleic Acid and Oligonucleotide Therapeutics Market: COVID-19 (2019-2024) & ($ millions) Figure 16. Nucleic Acid and Oligonucleotide Therapeutics in Other Figure 17. Global Nucleic Acid and Oligonucleotide Therapeutics Market: Other (2019-2024) & ($ millions) Figure 18. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application in 2023 Figure 19. Global Nucleic Acid and Oligonucleotide Therapeutics Revenue Market Share by Player in 2023 Figure 20. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024) Figure 21. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions) Figure 22. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions) Figure 23. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions) Figure 24. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2019-2024 ($ millions) Figure 25. Americas Nucleic Acid and Oligonucleotide Therapeutics Value Market Share by Country in 2023 Figure 26. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 27. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 28. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 29. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 30. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region in 2023 Figure 31. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) Figure 32. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) Figure 33. China Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 34. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 35. South Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 36. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 37. India Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 38. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 39. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Country in 2023 Figure 40. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) Figure 41. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) Figure 42. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 43. France Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 44. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 45. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 46. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 47. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share by Application (2019-2024) Figure 50. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 51. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 52. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 53. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 54. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size Growth 2019-2024 ($ millions) Figure 55. Americas Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 56. APAC Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 57. Europe Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 58. Middle East & Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 59. United States Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 60. Canada Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 61. Mexico Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 62. Brazil Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 63. China Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 64. Japan Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 65. Korea Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 66. Southeast Asia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 67. India Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 68. Australia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 69. Germany Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 70. France Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 71. UK Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 72. Italy Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 73. Russia Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 74. Egypt Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 75. South Africa Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 76. Israel Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 77. Turkey Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 78. GCC Countries Nucleic Acid and Oligonucleotide Therapeutics Market Size 2025-2030 ($ millions) Figure 79. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Type (2025-2030) Figure 80. Global Nucleic Acid and Oligonucleotide Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sarepta Therapeutics|||Ionis Pharmaceuticals|||Alnylam|||Biogen|||Nippon Shinyaku|||Sobi|||Novartis|||BioNTech|||Pfizer|||Moderna Therapeutics|||Jazz Pharmaceuticals|||CureVac|||Regulus Therapeutics|||ProQR|||Secarna|||MiNA Therapeutics|||Sylentis|||Arrowhead|||Silence Therapeutics|||Dicerna